Author:
Mostaghel Elahe A.,Montgomery Robert B.,Lin Daniel W.
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Labrie F, Cusan L, Gomez J, et al.: Major impact of hormonal therapy in localized prostate cancer: death can already be an exception. J Steroid Biochem Mol Biol 2004, 92:327–344.
2. Prostate Cancer Trialists’ Collaborative Group: Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Lancet 2000, 355:1491–1498.
3. Kumar S, Shelley M, Harrison C, et al.: Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane Database Syst Rev 2006, 4:CD006019.
4. Chen CD, Welsbie DS, Tran C, et al.: Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004, 10:33–39.
5. Scher HI, Sawyers CL: Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 2005, 23:8253–8261.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献